959585-30-9 Usage
General Description
2-(Quinolin-6-yl)propanoic acid, also known as 6-Quinolinylpropionic acid, is a chemical compound with a molecular formula C13H11NO2. It is a derivative of quinoline and is used in the synthesis of various pharmaceuticals and agrochemicals. The compound has been studied for its potential anti-inflammatory and analgesic properties, and it is also used in the development of new drugs for the treatment of various diseases. Additionally, 2-(quinolin-6-yl)propanoic acid has been investigated for its potential use as a chiral auxiliary in organic synthesis reactions. Its versatile properties and potential therapeutic applications make it a valuable chemical compound in pharmaceutical and research industries.
Check Digit Verification of cas no
The CAS Registry Mumber 959585-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,5,8 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 959585-30:
(8*9)+(7*5)+(6*9)+(5*5)+(4*8)+(3*5)+(2*3)+(1*0)=239
239 % 10 = 9
So 959585-30-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO2/c1-8(12(14)15)9-4-5-11-10(7-9)3-2-6-13-11/h2-8H,1H3,(H,14,15)
959585-30-9Relevant articles and documents
Lessons from (S)-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3- b ]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an inhibitor of receptor tyrosine kinase c-met with high protein kinase selectivity but broad phosphodiesterase family inhibition lea
Cui, J. Jean,Shen, Hong,Tran-Dubé, Michelle,Nambu, Mitchell,McTigue, Michele,Grodsky, Neil,Ryan, Kevin,Yamazaki, Shinji,Aguirre, Shirley,Parker, Max,Li, Qiuhua,Zou, Helen,Christensen, James
, p. 6651 - 6665 (2013/10/01)
The hepatocyte growth factor (HGF)/c-Met signaling axis is deregulated in many cancers and plays important roles in tumor invasive growth and metastasis. An exclusively selective c-Met inhibitor (S)-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)- [1,2,4]triazolo[4,3-
UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS
-
, (2010/01/29)
The present invention provides compounds Formula (I) that are gamma secretase modulators and are therefore useful for the treatment of diseases treatable by modulation of gamma secretase such as Alzheimer's disease. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.